2016/07/12 by Robert L. Page, Cindy L. O’Bryant, Davy Cheng +6 · 1 citation
Medicine · #Heart Failure Treatment and Management #Potassium and Related Disorders #Pharmaceutical Practices and Patient Outcomes #Medicine #Heart failure #Intensive care medicine #Exacerbation #Drug #Health care #Pharmacology #Internal medicine
paper · pdf · doi:10.1161/cir.0000000000000426
openalex publication_date 2016/07/12 · openalex created_date 2016/08/23 · openalex updated_date 2026/07/31
Heart failure is a common, costly, and debilitating syndrome that is associated with a highly complex drug regimen, a large number of comorbidities, and a large and often disparate number of healthcare providers. All of these factors conspire to increase the risk of heart failure exacerbation by direct myocardial toxicity, drug-drug interactions, or both. This scientific statement is designed to serve as a comprehensive and accessible source of drugs that may cause or exacerbate heart failure to assist healthcare providers in improving the quality of care for these patients.